- MGUS monoklonale Gammopathie unklarer Signifikanz
- SMM smoldering multiple Myeloma
(asyptomatisches Myelom)
asymptomatisches Myelom - SMM
+ MDE myeloma defining event
Konsequenz:
- Therapiestart
Definition:
International Myeloma Working Group criteria:
- Serum M protein >3 g/dL
- Light-chain restricted bone marrow plasma cells >10%
- oder 1 MDE (myeloma defining event)
- Knochenmark ≥60%
- abnormal FLC ratio ≥ 100 (involved kappa) or <0.01 (involved lambda)
- ≥2 focal lesions on MRI
- Serumelektrophorese
- Knochenmarkbiopsie
- Niere,Elo,Blutbild, Skelett-Rö, MR Wirbelsäule-Becken